Immunotherapy of rheumatoid arthritis.
Open Access
- 1 May 1992
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 51 (5) , 577-579
- https://doi.org/10.1136/ard.51.5.577
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Immunological follow up of 13 patients with rheumatoid arthritis treated by anti-T CD4+ monoclonal antibodiesJournal of Autoimmunity, 1992
- Immunosuppressive drug therapy for rheumatic diseaseCurrent Opinion in Rheumatology, 1991
- Treatment of rheumatoid arthritis with monoclonal CD4 antibody M‐T151. Clinical results and immunopharmacologic effects in an open study, including repeated administrationArthritis & Rheumatism, 1991
- Human anti-mouse antibody response induced by anti-CD4 monoclonal antibody therapy in patients with rheumatoid arthritisClinical Immunology and Immunopathology, 1991
- Treatment of rheumatoid arthritis with an anti‐CD4 monoclonal antibodyArthritis & Rheumatism, 1991
- The induction of skin graft tolerance in major histocompatibility complex‐mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti‐CD4 and anti‐CD8 antibodiesEuropean Journal of Immunology, 1990
- IMMUNOGENETIC AND CELLULAR IMMUNE MECHANISMS IN RHEUMATOID ARTHRITIS: RELEVANCE TO NEW THERAPEUTIC STRATEGIESRheumatology, 1990
- Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventionCell, 1988
- LYMPHOCYTAPHERESIS–A FEASIBLE TREATMENT FOR RHEUMATOID ARTHRITISRheumatology, 1986
- Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4.The Journal of Experimental Medicine, 1985